Ares Financial Consulting’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
1,799
+79
+5% +$18.4K 0.33% 52
2026
Q1
$420K Buy
1,720
+361
+27% +$84.1K 0.33% 51
2025
Q4
$281K Buy
+1,359
New +$269K 0.27% 61

Other funds holding JNJ

Ares Financial Consulting's JNJ Position: Q2 2026 in Review

Ares Financial Consulting increased its Johnson & Johnson (JNJ) stake by 4.6% in Q2 2026, buying an estimated $18.4K and bringing the position to 1,799 shares worth $457K. The position accounts for 0.33% of the portfolio, ranked #52.

Ares Financial Consulting first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 2,805 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ares Financial Consulting held 1,799 shares of Johnson & Johnson worth $457K as of Q2 2026.
  • Ares Financial Consulting bought 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
  • Johnson & Johnson made up 0.33% of Ares Financial Consulting's portfolio in Q2 2026, its #52 holding.
  • Ares Financial Consulting first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 2,805 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.